BLT announces Planned Director Retirement

Planned Director Retirement Veronica Aris has advised of her intention to retire as a director and will not be seeking re-election at the annual shareholder meeting this year which will reduce the number of directors to five (5). The Board is not seeking to fill this vacancy. The Board has determined that based on the Company's current size and stage of development that an optimal number of directors is five. Each year as part of the board's annual review process the capability mix is assessed to evolve in line with Company's future development and international growth plan requirements. When the Board's succession planning anticipates an upcoming vacancy to be filled or further director capability has been identified, professional search services are used to assist the Board in identifying suitable candidates for nomination. Veronica has been a director since 2014 and on behalf of the Board I would like to take this opportunity to thank her for her contribution over this time. Tony Offen Chair Mob: 021 463 336 About Blis Technologies Ltd. Delivering proven health benefits through evidence-based, advanced probiotics. Blis is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support and teeth and gum health. BLIS products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz End CA:00335099 For:BLT Type:GENERAL Time:2019-05-27 13:12:04